Cardiology Today


The following articles appeared in the print edition of CARDIOLOGY TODAY.

Table of Contents
Cover Story

Nonobstructive CAD remains vexing, especially in women

FDA News

FDA approves ready-to-use version of bivalirudin for PCI

Percutaneous heart pumps gain new indications

In the Journals

Migraines increase risk for CVD

Program improves heart-healthy restaurant offerings in rural areas

Stroke, CHD risk persist with minimal cigarette consumption

Predictors, safety of next-day discharge after TAVR confirmed

In-hospital mortality in AF more prevalent in rural hospitals

CVD risk may increase with breast cancer treatment

Survival decreases in in-hospital cardiac arrest during off-hours

Elevated high-sensitivity cardiac troponin predicts incident HF

AHA: Mortality from uncontrolled BP rises; CVD leading cause of death in US

Readmissions higher in women with acute MI, cardiogenic shock

Replacing sitting with standing may aid in long-term weight loss

Rates of HF, common cancers similar in socioeconomically deprived patients

Industry News

In its 15th year, National Wear Red Day increases awareness of women's heart health

Meeting News

Thrombectomy improved outcomes in patients with stroke, salvageable brain tissue

Technology may treat fluid overload in congestive HF

Clot-busting drugs after stroke given less to patients with cancer

Mechanical thrombectomy, IV alteplase recommendations updated in new stroke guidelines

Medical therapy for PAD making great strides

Women with PAD may respond differently to DCB treatment

On the Pulse

#SoMe for the busy physician

Sheila Sahni, MD; M. Chadi Alraies, MD

Pharmacology Consult

Lipid-lowering therapy for primary prevention of CV events: Navigating the guidelines

Joshua Jacobs, PharmD; Bonnie Kaminsky, PharmD, BCPS; Scott Yost, PharmD, BCPS

Trial Scorecards

Trial Scorecard: ACS QUIK

Trial Scorecard: DECREASE-PCI

Trial Scorecard: DEFUSE 3

Trial Scorecard: EXTEND-IA TNK

Trial Scorecard: LEADLESS

Trial Scorecard: PROPER

Trial Scorecard: DESERVE

Trial Scorecard: EJECTION-HF